Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyTue, 28 May 2024 01:49:55 +0200Fri, 26 Apr 2024 09:49:00 +0200Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine,elasomeran,elasomeran / imelasomeran,elasomeran / davesomeran,andusomeran, Date of authorisation: 06/01/2021, Revision: 45, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/spikevax-previously-covid-19-vaccine-modernaHuman medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine,elasomeran,elasomeran / imelasomeran,elasomeran / davesomeran,andusomeran, Date of authorisation: 06/01/2021, Revision: 45, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/spikevax-previously-covid-19-vaccine-modernaFri, 26 Apr 2024 09:49:00 +0200Human medicineSpikevax (previously COVID-19 Vaccine Moderna): EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5791-en_2.pdfSpikevax (previously COVID-19 Vaccine Moderna): EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5791-en_2.pdfThu, 11 Apr 2024 15:02:00 +0200Human medicine